Recifercept clinical trials
Also written PF-07256472.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How each study uses recifercept is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses recifercept is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With AchondroplasiaTerminatedPhase 2PfizerNCT04638153Written as Recifercept
- Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in AchondroplasiaTerminatedPhase 2PfizerNCT05116046Written as Recifercept
- Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese ParticipantsWithdrawnPhase 1PfizerNCT05061277Written as Recifercept
- Study To Evaluate The Pharmacokinetic, Safety And Tolerability Of Single Or Multiple Subcutaneous Doses of ReciferceptCompletedPhase 1PfizerNCT04543344Written as Recifercept
Codes
What other systems call recifercept · ClinicalTrials.gg INT015171
- UNII (FDA) 620C079F3IRECIFERCEPTOne source FDA
- NCI Thesaurus C175197ReciferceptOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 620C079F3I | RECIFERCEPT | One source FDA |
| NCI Thesaurus | C175197 | Recifercept | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.